1 PLACE - 3 HIGHLIGHTS:
A dedicated area to companies developing and expanding new technologies in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
NETWORK IN THE HUB
This is your opportunity to discover new ideas from companies that are at an early-stage and want to know if their product may match the market's expectations.
A patented idea can become the next big thing in pharma packaging: come, listen and support them!
THE COMPANIES EXHIBITING IN 2018:
CPI (The Centre for Process Innovation)
CPI is a UK based technology innovation centre. They have extensive multi-disciplinary expertise to meet the future demands of the healthcare industry. Working closely with their network of clinical, academic and industrial partners, they help companies translate and validate their products and processes into impactful solutions for the pharmaceutical and medical technology sectors.
Saralon is a spin-off from the Institute of Print and Media Technology – University of Technology in Chemnitz (pmTUC). The team at Saralon has accumulated unrivalled expertise and in-depth knowledge of printed electronics. The company not only offers specialist expertise in the development and
manufacture of advanced printing inks, but also in circuit design, package design, package production and printing.
THE COMPANIES PITCHING IN 2018:
IN PARTNERSHIP WITH EARLYMETRICS
Early Metrics is the international rating agency for startups and innovative SMEs, assessing their growth potential through the analysis of a venture’s key non-financial metrics. Our ratings provide increased transparency for corporate decision-makers, who use them as a risk management and quality benchmarking tool before engaging with future innovative service providers. Startups get an independent audit that supports their deployment.
Established in London, Paris and Tel Aviv, Early Metrics has rated more than 1400 startups and works on behalf of medtech and healthtech investors, as well as corporate clients such as Sanofi, Servier, Johnson & Johnson, and Pierre Fabre.